SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,000 | -13.6% | 652 | -5.1% | 0.00% | 0.0% |
| Q1 2022 | $22,000 | +10.0% | 687 | -1.0% | 0.00% | +33.3% |
| Q4 2021 | $20,000 | +5.3% | 694 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $19,000 | -5.0% | 694 | +5.3% | 0.00% | -25.0% |
| Q2 2021 | $20,000 | +17.6% | 659 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $17,000 | 0.0% | 659 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $17,000 | +21.4% | 659 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $14,000 | -12.5% | 659 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $16,000 | +33.3% | 659 | +2.0% | 0.01% | +20.0% |
| Q1 2020 | $12,000 | -50.0% | 646 | -35.4% | 0.01% | -44.4% |
| Q4 2019 | $24,000 | -11.1% | 1,000 | 0.0% | 0.01% | -25.0% |
| Q3 2019 | $27,000 | -18.2% | 1,000 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $33,000 | – | 1,000 | – | 0.01% | – |
| Q4 2018 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |